Optometrists in Talihina, OK Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Mr. Olin W Fenton, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 Dallas St, Talihina, OK 74571 Phone: 918-567-3424 Fax: 918-567-3420 |
 North East Family Eyecare Pc Optometrist - Low Vision Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 200 Dallas St, Talihina, OK 74571 Phone: 903-244-2889 Fax: 918-567-3240 |
Dr. Dakota Smith Waldroop, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Choctaw Way, Talihina, OK 74571 Phone: 918-457-7000 |
Dr. Michael Glenn Williams, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1 Choctaw Way, Talihina, OK 74571 Phone: 918-567-7000 |
News Archive
Highly active antiretroviral therapy might increase risk of asthma in young children
Highly active antiretroviral therapy might increase the risk of asthma among children because of the therapy's effect on the immune system and CD4+ T cell levels, according to a study recently published in the Journal of Allergy and Clinical Immunology, Reuters reports.
New clinical practice guideline for prostate cancer screening released at 2013 AUA Annual Meeting
Men ages 55 to 69 who are considering prostate cancer screening should talk with their doctors about the benefits and harms of testing and proceed based on their personal values and preferences, according to a new clinical practice guideline released today by the American Urological Association.
New review outlines key challenges and solutions to address growing burden of fragility fractures
With the first of the baby boomer generation now entering their eighties, the next decade will see a significant increase in the number of people living with osteoporosis and experiencing the often devastating outcome of fragility fractures.
Cardiac Network awaits servicing its agreement with AWH; continues to expand its technology development
Cardiac Network, Inc. (PINKSHEETS: CNWI) reported today that it is continuing the expansion of its technology development initiatives for its products and services in anticipation of servicing its agreement with American Wholesale Health, or AWH, that was announced on June 22, 2009.
FDA grants Priority Review to Lilly's ramucirumab for treatment of advanced gastric cancer
Eli Lilly and Company today announced that the U.S. Food and Drug Administration has assigned Priority Review to the regulatory submission for ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial chemotherapy.
› Verified 4 days ago
Physical Therapists
Optometrists
Podiatrists
Speech-Language Pathologists
Occupational Therapists